Signaling Mechanisms in Salivary Gland Cells
唾液腺细胞的信号传导机制
基本信息
- 批准号:7558563
- 负责人:
- 金额:$ 37.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-07-15 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:Adrenergic ReceptorAgonistAntibodiesAttenuatedBindingBiological AssayBiological ModelsBiotinylationBrainCell membraneCell physiologyCellsComplexDataDevelopmentElectrolytesEndoplasmic ReticulumEpidermal Growth Factor ReceptorFluids and SecretionsFluorescenceFunctional disorderG Protein-Coupled Receptor GenesG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGlycerolGoalsHomologous GeneHormonesKnock-outLeadLiquid substanceMediatingMembrane PotentialsModelingMouth DiseasesMusMuscarinicsN-terminalNeurabinNeurotransmittersPlayProteinsPumpRGS ProteinsRGS2 geneRadiationRegulationReportingResearch PersonnelRetrievalRoleRyanodine Receptor Calcium Release ChannelRyanodine ReceptorsSTIM1 geneSalivary GlandsScaffolding ProteinSchemeSignal TransductionSignaling ProteinSjogren&aposs SyndromeTechniquesTestingWestern BlottingWorkXerostomiabasolateral membranein vivoluminal membranenovelparotid cellprogramsreceptorscaffoldspinophilintrafficking
项目摘要
DESCRIPTION (provided by applicant): Ca2+ signaling regulate fluid and electrolyte secretion by salivary gland (SG) cells. This polarized function of SG dictates polarized organization and functioning of Ca2+ signaling complexes in cellular microdomains. Scaffolding proteins plays critical roles in the assembly AND regulation of Ca2+ signaling proteins within the complexes. A central component of the Ca2+ signaling complexes is Ca2+ influx, which is mediated by TRPC channels. TRPC3 and TRPC6 are the dominant channels in SG. How the scaffolds Spinophilin (SPL), Neurabin (NRB) and Homerl regulates the action of GPCRs and TRPC3/6 channels is the theme of this proposal. Towards achieving our goals we found the regulation of Ca2+ signaling by the SPL/NRB pair, the role of Homerl in trafficking of TRPC channels, regulation of TRPC6 activity by SPL and by the newly discovered STIM1. These findings led to development of the following specific aims to probe the role of scaffolds in SG Ca2+ signaling. 1. Determine the role of SPL/NRB in regulating GPCRs Ca2+ signaling by RGS proteins in SG cells. This will be achieved by a) Identifying the NRB domain that binds RGS proteins and the relationship between SPL and NRB binding of RGS proteins, b) Determining the role of NRB in Ca2+ signaling in RGS2-/- and NRB-/- cells and c) Characterizing Ca2+ signaling in SG cells from SPL-/- and NRB-/- mice. 2. Explore the role of Homerl in TRPC channels translocation and Ca2+ influx by: a) studying translocation and retrieval of TRPC3/6 in SG cells and the role of store depletion and Homerl in both activities; b) Extend the findings in native cells by studying translocation of TRPC3/6-YFP expressed in HEK cells by biotinylation and TIRF assays. 3. Study regulation of TRPC3/6 by SPL/NRB by: a) Identifying the two SPL/NRB domains that interact with TRPC3/6; b) determine the effect of SPL/NRB in TRPC3/6 translocation and retrieval; c) characterize the regulation of TRPC3/6 channel activity by SPL/NRB in vivo using SPL-/- and NRB-/- cells. 4. Study regulation of TRPC3/6 by STIM1 by: a) determine the regulation of NATIVE and expressed TRP3/6 channels by STIM1, b) explore the mechanism by which STIM1 regulates TRPC3/6. The proposed work explores novel regulatory mechanisms in Ca2+ signaling and their relevance to regulation of SG fluid and electrolyte secretion.
描述(申请人提供):钙信号调节唾液腺(SG)细胞的液体和电解质分泌。SG的这种极化功能决定了细胞微域中钙信号复合体的极化组织和功能。支架蛋白在钙信号蛋白在复合体中的组装和调节中起着关键作用。钙信号复合体的中心成分是钙内流,它是由TRPC通道介导的。在SG中,TRPC3和TRPC6是主要通道。亲刺素(SPL)、神经降压素(NRB)和Hmer如何调节GPCRs和TRPC3/6通道的作用是本提案的主题。为了实现我们的目标,我们发现了SPL/NRB对钙信号的调节,Hmer在TRPC通道运输中的作用,SPL和新发现的STIM1对TRPC6活性的调节。这些发现导致了以下特定目标的发展,以探索支架在SG钙信号转导中的作用。1.确定SPL/NRB在RGS蛋白调节SG细胞GPCRs钙信号通路中的作用。这将通过a)确定与RGS蛋白结合的NRB结构域以及SPL与RGS蛋白的NRB结合之间的关系,b)确定NRB在RGS2-/-和NRB-/-细胞中的钙信号转导中的作用,以及c)表征SPL-/-和NRB-/-小鼠SG细胞中的钙信号。2.通过研究TRPC3/6在SG细胞中的转位和恢复,以及贮备物耗竭和Hmer在这两种活动中的作用,探讨Hmer在TRPC通道转位和钙内流中的作用;b)通过生物素化和TIRF方法研究在HEK细胞中表达的TRPC3/6-YFP的转位,从而扩展了在天然细胞中的发现。3.研究SPL/NRB对TRPC3/6的调节:a)鉴定与TRPC3/6相互作用的两个SPL/NRB结构域;b)确定SPL/NRB在TRPC3/6转位和恢复中的作用;c)利用SPL-/-和NRB-/-细胞在体内表征SPL/NRB对TRPC3/6通道活性的调节。4.研究STIM1对TRPC3/6的调控:a)确定STIM1对天然和表达的TRP3/6通道的调控;b)探讨STIM1调控TRPC3/6的机制。本工作探索了钙信号中新的调控机制及其与脑脊液和电解质分泌的调节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shmuel Muallem其他文献
Shmuel Muallem的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shmuel Muallem', 18)}}的其他基金
Hormone Regulation of [Ca2+] in Pancreatic Acinar Cells
胰腺腺泡细胞中[Ca2]的激素调节
- 批准号:
7905573 - 财政年份:2009
- 资助金额:
$ 37.65万 - 项目类别:
Molecular Mechanisms of HCO3- Secretion by the Pancreatic Duct
胰管分泌 HCO3- 的分子机制
- 批准号:
7464514 - 财政年份:2009
- 资助金额:
$ 37.65万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 37.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 37.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 37.65万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 37.65万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 37.65万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 37.65万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 37.65万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 37.65万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 37.65万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 37.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




